We have generated a null allele of the mouse Msxl homeobox gene by insertion of an nlacZ reporter gene into its homeobox. The sensitivity of/~-galactosidase detection permitted us to reveal novel aspects of Msxl gene expression in heterozygous embryos, in particular in ectoderm and mesoderm during gastrulation, and in migrating neural crest cells. Homozygous mutant mice die at birth with facial defects (see Satokata, I. and Maas, R. (1994) Msxl deficient mice exhibit cleft palate and abnormalities of craniofacial and tooth development. Nat. Genet. 6, 348-356). To investigate the reason for this limited phenotype, we compared the pattern of Msxl expression with that of the closely related Msx2 gene in wild type embryos and in Msxl -/-mutants. Notably, whereas the expression of Msxl and Msx2 overlap in the developing limb, this is not the case in the facial regions most affected in the mutant. © 1997 Elsevier Science Ireland Ltd.
Introduction
The expression of the homeobox containing gene, Msxl is associated with epithelio-mesenchymal interactions at many sites in vertebrates (Hill et al., 1989; Robert et al., 1989; Pavlova et al., 1994) . In particular, Msxl is expressed in the limb field somatopleural mesoderm as it is induced to proliferate and form a bud. This bud induces differentiation in the overlying ectoderm of a transitory, pseudostratified epithelium, the apical ectodermal ridge (AER), which also expresses Msxl, but at a lower level than the mesoderm. Diffusible molecules from the AER subsequently act on the underlying mesoderm to regulate proliferation, apoptosis, tissue polarity and differentiation. In the distal limb mesoderm these signals maintain Msxl expression, which may constitute an important mediator of their action (Coelho et al., 1991; Robert et al., 1991) . Through similar mechanisms, Msxl is regulated in the distal jaw mesenchyme by the overlying ectoderm (Brown et al., 1993) , in the mesenchyme of the tooth bud by the oral ectoderm (Jowett et al., 1993) and in the epithelium of the uterus under the control of the uterine mesenchyme (Pavlova et al., 1994) . It has been proposed that Msxl constitutes an early response to diffusible signals such as Bmp4 in tooth and dorsal mesenchyme, Fgfs in limbs and Wnt5a in the uterus. Many other sites such as the dorsal neural tube, cephalic neural crest cells, eye and ear are places for Msxl expression where it may also be regulated through inductive interactions, although induction at these sites is less well documented (reviewed in Davidson, 1995; Monsoro-Burq et al., 1996) .
Most of the potential functions of this gene during development have been deduced from the pattern of expression of its transcripts in normal and manipulated embryos. It has been proposed that it may act as a general regulator of proliferation/differentiation choices and possibly also as a regulator of apoptosis (reviewed in Davidson, 1995) .
A null mutation in the Msxl gene has been reported (Satokata and Maas, 1994) . Homozygous mutants die at birth; they exhibit facial defects including a complete cleft of the secondary palate, interruption of tooth differentiation and middle ear defects, as well as some minor defects in the skull. The only defect which correlates directly with the suggested role of Msxl in inductive interactions comes from the tooth phenotype where a block in differentiation occurs at the early bud stage, when the inductive potential shifts from the oral ectoderm to the Msxl expressing mesenchyme (for review see Lumsden, 1988; Thesleff et al., 1995; Thesleff and Sahlberg, 1996) . In the mutant, the mesenchyme fails to condense and tooth differentiation is interrupted (Satokata and Maas, 1994; Chen et al., 1996) . It is unclear whether the cleft palate defect is primary or secondary, consecutive to the slight shortening of the jaw. The unexpected absence of defects in other structures such as the limbs may result from functional redundancy either through alternative physiological pathways or through complementation by proteins of the same family which may compensate for the lack of Msxl protein.
Msxl belongs to a small family of genes encoding proteins with close biochemical properties. The duplication of one ancestral msx-related gene, expressed in the neural tube, to give several genes appears to be correlated with the emergence of vertebrates in evolution (Holland et al., 1994) . In mice, three msx-related genes have been isolated.
They share 98% homology in the homeodomain, making this family one of the most conserved during evolution (Davidson, 1995; Wang et al., 1996) . It has been suggested that while the Msx3 gene, for which expression is restricted to the neural tube, has retained ancestral-like characteristics (Shimeld et al., 1996; Wang et al., 1996) , an Msxl,2 gene acquired new regulatory elements and became involved in the control of some aspects of vertebrate-specific tissue differentiation (i.e. neural crest cell derivatives, paired sensory organs and teeth) (Holland et al., 1994) , before its duplication into Msxl and Msx2. In agreement with this hypothesis, Msxl and Msx2 have very similar although not identical patterns of expression in many tissues (reviewed in Davidson, 1995) . In vitro, both proteins exhibit similar DNA binding specificity and function as repressors in the absence of DNA binding sites . Hence, it is possible that in many tissues the absence of the Msxl protein may be compensated by Msx2.
Using homologous recombination in embryonic stem cells, we have generated mice carrying a null mutation in the Msxl gene by insertion of the bacterial nlacZ reporter gene into the homeobox. Using the nlacZ reporter as a sensitive marker, we refine the analysis of Msxl expression at some sites, especially during early stages of development. The nlacZ marker also permits further analysis of the mutant phenotype and comparison with the Msx2 pattern of expression. The nlacZ gene was ligated with a 1.1 kb Neo gene, under the control of the tk promoter, and the whole fragment was integrated in phase into the coding sequence of the third helix of the Msxl homeodomain. The diphtheria toxin A gene (DTA) driven by a thymidine kinase promoter was used for counterselection of non-targeted events. Boxes represent coding parts of the genes as follows: black, the homeodomain; dark shaded, the Msxl exons except the homeodomain; white, the nlacZ and neo genes integrated into the Msxl homeodomain as well as the plasmid on each side of the construct; light shaded, the DTA gene. Scale bar = 1.2 kb. (b) An ES cell clone in which the construct has been recombined in the Msxl locus. The nlacZ gene, now under the control of the Msxl promoter, is expressed in some of the ES cells, providing an easy screen for homologous recombination events. (c) Southern analysis of fetal DNA derived from heterozygous crosses. The mutated allele (6 kbp) is distinguished from the endogenous allele (5 kbp) by using a 3.5 kbp BgllI-BgllI probe encompassing most of the second exon and 3' untranslated sequences to reveal EcoRI digested fragments. H, homozygote; h, heterozygote; w, wild type. (d) PCR analysis of fetal DNA derived from heterozygous crosses. A 600 nucleotide fragment was amplified from the Msxl endogenous locus in wild type and heterozygous embryos. PCR primers, located on both sides of the nlacZ-neo integration site (see Section 4), were displaced by 4.5 kb in the mutated locus such that amplification no longer occurred. Therefore, in homozygous (H) embryos containing only the mutated locus, the 600 nucleotide fragment is absent. An 800 nucleotide length fragment amplified with primers specific for the nlacZ gene (see Section 4) was used as an indicator of the insertion and is present in heterozygous (h) and homozygous (H) embryos but absent from wild type (w) embryos. /3-Galactosidase activity is detected in most of the ectoderm and mesoderm, ea, ectodermal part of the amnion; em, embryonic mesoderm; hf, headfold; ma, mesodermal part of the amnion; yse, yolk sac endoderm. (b) Whole-mount/3-galactosidase stained E8.5 embryo showing strong staining in the posterior region of the embryo and in the amnios (a). hf, headfold; ht, heart. (c) Transverse section through the posterior region of an E9.5 (18 somite) embryo showing strong/3-galactosidase activity in the neural tube (nt), the lateral mesoderm (splanchnopleural (sp) and somatopleural (sm)) and the ventral part of the hindgut (g). Note also some labelled cells in the paraxial presomitic mesoderm and in the axial mesoderm (notochord (nc)). Cells in the ectoderm (e) are also labelled. (d) The same embryo as in (c) showing a transverse section through a rather more anterior domain. Note the weakened expression in the splanchnopleure (sp) and gut (g), the absence of detectable expression in paraxial mesoderm (somite (s)) as well as restriction of the/3-galactosidase activity to the dorsal-most portion of the neural tube (nt) and neural crest cells (ncc) which have left it./3-Galactosidase is also detected in the intermediate mesoderm (im, Wolffian duct), sm, somatopleure. (e) Detection of/3-galactosidase activity in an E9.5 (18 somite) embryo viewed dorsally./3-Galactosidase activity is detected in the neural crest cells (ncc) as they leave the dorsal neural tube (nt). Note/3-galactosidase activity in the whole forelimb bud (fl) at this stage. (f) Detection of/3-galactosidase activity in the migrating cephalic neural crest cells (arrowheads) and in the otic vesicle (o). Note strong migration from rhombomeres (r) 2, 4 and 6, weaker and delayed migration from rhombomere 3 and weak migration from rhombomere 5. Inset, rhombomeric region of an embryo of the same age after a short time staining for/3-galactosidase. Note the stronger labelling of rhombomere 3 and 5 and the weaker labelling of rhombomeres 2, 4 and 6. Scale bars = 100/~m. 
Homologous recombination
The nlacZ reporter gene was integrated, in frame, into the sequence encoding the third helix of the homeodomaln of the Msxl gene by homologous recombination (Fig. la) , in order to facilitate analysis of Msxl expressing cells in the embryo. The nuclear localization signal (n) concentrates the /3-galactosidase to the nuclear membrane resulting in increased sensitivity and resolution at the single cell level. In transient transfection assays using different cell lines, no transcriptional activity is observed from 5' sequences extending to the BamHI site upstream of exon 1 (S. Gonzales, L. Ferland, B. Robert and E. Abdelhay, submitted). Hence, we constructed an integration vector that does not contain any functional promoter sequence, such that its random insertion into the genome should not lead to the production of/3-galactosidase. Clones of embryonic stem (ES) cells resistant to G418 were selected after transfection. Nuclear/3-galactosidase activity was clearly detectable in some of them (Fig. lb) ; 14 out of 15 clones with/3-galactosidase positive cells were homologous recombinants, as shown by Southern blotting (Fig. lc) , while the non-expressing clones were not. The presence of the nlacZ insertion was verified by PCR analysis (Fig. ld) . Some clones showed very weak diffuse staining, but none of these were homologous recombinants. Expression of the endogenous Msxl gene was not detectable by Northern blotting in dividing compared with differentiating ES cell cultures. The fact that some /3-galactosidase positive cells are seen within clones which have undergone homologous recombination probably reflects the onset of differentiation of some cells within the clone. The staining of these clones provides a rapid and easy screen for homologous recombination events. Such clones can then be propagated under growth conditions and checked by Southern blotting prior to blastocyst injection.
The fusion mRNA Msxl-nlacZ contains 5' sequences from the Msxl mRNA including the AUG and codons for the first 43 amino acids. Therefore, we expected its translation properties and stability to be close to that of Msxl. In embryos, the /3-galactosidase activity profile does indeed mimic the Msxl mRNA accumulation pattern (compare Fig. 4a and b) at all sites where this has been detected.
Msxl expression in heterozygous embryos
Little is known about the early sites of Msxl expression in the embryo Lyons et al., 1992; Davidson, 1995) . At about embryonic day 6.5 (E6.5), Msxl expression is confined to extraembryonic tissues (Lyons et al., 1992 and our unpublished results) .
In the ectoderm,/3-galactosidase was detected at the time of gastrulation (E8.0), both in the future dorsal ectoderm and in the neuroepithelium (Fig. 2a) . At E8.5, Msxl is already downregulated in anterior non-neural ectoderm, but is still present throughout the neural tube, from the prospective forebrain to its caudalmost part (Fig. 2b) . Fig. 2c,d presents sections from two different levels along the anteroposterior axis of the same 18 somite (E9.5) embryo. The antero-posterior gradient of development permits comparison of two different stages of neural tube development. In Fig. 2c , the entire open neuroepithelium expresses the nlacZ reporter, while in the more mature neural tube,/3-galactosidase activity is restricted to the dorsal half (Fig. 2d) . In older embryos, expression is restricted to the most dorsal part of the neural tube (data not shown).
Msxl expression, as detected by/5-galactosidase activity, is expressed in the mesoderm as soon as it emerges from the primitive streak (Fig. 2a) . It is expressed in all the mesoderm (embryonic as well as extraembryonic) (Fig. 2a and data not shown). In a whole-mount stained embryo at E8.5, the nlacZ gene is expressed in all the posterior mesoderm ( Fig. 2b) . At E9.5, in an 18 somite embryo, the/~-galactosidase activity was still detected, at a low level, in some cells of the paraxial (presomitic) and axial (notochord) mesoderm in the posterior part of the embryo (Fig. 2c ) but had already disappeared from somites in the more anterior part (Fig. 2d) . At this stage, Msxl is also expressed in the intermediate mesoderm (Fig. 2d) . It is also strongly expressed in the lateral mesoderm, initially at equivalent levels in the splanchnopleure and somatopleure (Fig. 2c) , but subsequently mainly in the somatopleure (Fig. 2d) . Msxl remains expressed in the somatopleure and its derivatives (e,g. the limb bud) until late in development (e.g. at El0.5, Fig. 4b and Fig. 5a,d ). At E13.5, expression in the lateral mesoderm is restricted to the region of the body wall where closure is still taking place (Fig. 3d) .
We also detected 13-galactosidase positive cells in the ventral part of the gut (Fig. 2c,d ). The expression is only transient, since later in development (El0), no expression was detected in this structure (data not shown).
Msxl expression in neural crest cells
Msxl is expressed in migratory neural crest cells (Hill et al., 1989; Robert et al., 1989; Lyons et al., 1992) . Again, the sensitivity of /3-galactosidase detection permitted us to detect expression in trunk neural crest cells at the beginning of their migration from the dorsal neural tube along the dorsal pathway (Fig. 2e) , a pathway which is followed by melanocyte precursors (Erickson and Goins, 1995) . The nlacZ reporter gene is quickly downregulated in this population, and therefore cannot be used as a marker of neural crest cells later during their migration. Msxl is also expressed in neural crest cells migrating through the ventral pathway (data not shown) in cells which will subsequently give rise to the peripheral nervous system as well as neuroendocrine and paraendocrine derivatives (Le Douarin, 1982) .
We detected an nlacZ expression which was transiently stronger in rhombomeres 3 and 5 than in rhombomeres 2, 4 and 6 at the 18 somite stage (Fig. 2f and inset therein) . In strongly stained embryos, cells outside the rhombomeres were also seen to express the reporter gene (Fig. 2f) , suggesting that independent streams of neural crest cells which originate from each rhombomere are distinguishable by Msxl expression. From this observation, it would appear that not all the neural crest cells are depleted from rhombomeres 3 and 5 even if they provide fewer neural crest cells than rhombomeres 4 and 6. This observation is not consistent with a neural crest cell lineage analysis where streams of migrating cells lateral to rhombomeres 3 and 5 were not detected (Lumsden et al., 1991; Serbedzija et al., 1992; Sechrist et al., 1993) . However, these rhombomeres have been shown to produce neural crest cells (Serbedzija et al., 1992; Sechrist et al., 1993) and it would be of interest to investigate further whether, in the mouse, some of these cells spread within mesenchyme adjacent to the neural tube.
Reporter gene expression was also detected in the mammary gland at Ell.5 and E13.5, in males as well as in females (Fig. 3d, arrowheads) . /3-Galactosidase was detected in the wall of the blood vessels from El3 to birth (Fig. 3d) , most easily seen in homozygous embryos where two copies of nlacZ gene are present.
Msxl-nlacZ homozygous mutant phenotype
Mice heterozygous for the mutation were alive and fertile. In contrast, homozygous animals exhibited a gasping breathing, became cyanotic, and died a few hours after birth. Air was found in the stomach and intestine as described by Satokata and Maas (1994) . When backcrossed on the C57BL/6J background, we found that death occurred more rapidly and these animals had less air in their stomach compared with homozygotes on a mixed genetic background.
Exploiting the nlacZ insertion in the Msxl gene, we observed no significant difference between homozygotes and heterozygotes in the reporter gene expression pattern initially (Fig. 3a) . Therefore, we conclude that in spite of the fact that the Msxl promoter contains a consensus binding site for the gene product (Kuzuoka et al., 1994) , this is not required to regulate its own expression. At all stages analyzed, the reporter gene expression pattern tended to be stronger in homozygotes than in heterozygotes probably due to nlacZ gene dosage (compare homozygote and heterozygote in Fig. 3d ). The first clear morphological difference was observed at about El3, when the mandibular development of the homozygote was slightly delayed, leading to a cleft chin (Fig. 3e, arrowhead) . At this stage, the shape of the secondary palate was also slightly modified (data not shown). At birth, the head of the homozygote was more rounded and shortened (Fig. 3b) than that of the heterozygote. This is particularly striking in the snout which derives from the frontonasal process. All the homozygous mutants exhibited a complete cleft of the secondary palate.
Skeletal preparations of new-born individuals revealed the absence of alveolar processes due to failure of development of molar teeth (Fig. 3c ,f, black arrows) (see also Satokata and Maas, 1994) . The incisors were also absent in the homozygous mutant (Fig. 3c,f, white arrows) . The molars developed until E13.5 and reached the bud stage but failed to develop further. The nlacZ reporter gene was induced normally in the mesenchyme at E13.5 (data not shown), but the mesenchyme did not seem to acquire the ability to sustain differentiation of the tooth epithelium (Satokata and Maas, 1994; Chen et al., 1996) . /3-Galactosidase labelling was seen in the developing ears in the otic vesicle which formed the inner ear as a result of interactions with the neural tube ( Fig. 2f ; Wu and Oh, 1996) , in the branchial arches which gave rise to the ossicles of the middle ear (Fig.  4b) , and in the external ear during its formation (Fig. 3d,e) . In the homozygotes, the only defect seen in the ear was located in the middle ear, where the short process of the malleus was missing (Fig. 3c,f , arrowhead, and Satokata and Maas, 1994) .
Comparison between Msxl and Msx2 patterns of expression
Although Msxl is expressed at many sites during development, only certain cranio-facial derivatives are altered in the homozygous mutants (Satokata and Maas, 1994 and our results) . Surprisingly, no defect in the limb was seen (Figs 3, and 5) although Msxl is strongly expressed during critical stages of limb development (Fig. 4a,b and Fig. 5a, d) .
To check the possibility of compensation by the Msx2 protein in the limb, the patterns of expression of these two genes were analyzed by in situ hybridization. At E9.5, both genes were expressed in the whole limb bud (data not shown), although Msx2 was expressed weakly and the limit of its domain of expression was not easy to determine. At E10.5, both genes were expressed in the limb; Msxl was expressed widely in the progress zone (Fig. 4a,b) , while Msx2 was mainly restricted to anterior and posterior regions (Fig. 4c) , as well as being expressed in the apical ectodermal ridge. No extension of Msx2 expression was detected in the mutant (Fig. 4d) . At E11.5, Msxl was maintained in the progress zone (Fig. 5a ) and subsequently restricted to the interdigital apoptotic area (Fig. 5d) . In wild type embryos, Msx2 was expressed in the same area but apparently at a lower level (Fig. 5b,e) . No difference in the expression pattern was observed in the mutant embryos (Fig. 5c,f) . We would suggest that the pattern of expression of Msxl and Msx2 in the limb is sufficiently similar between E9.5 and E12.5 to permit Msx2 to compensate for Msxl despite our observations that there does not appear to be an upregulation of Msx2 in the mutant. Note that Msx2 is strongly expressed in the otic vesicle (Fig. 4c) while Msxl is only expressed in the region neighbouring the neural tube (Fig. 4a,b) . In this case, the broader expression pattern of the Msx2 gene probably explains the absence of a phenotype in the inner ear.
In contrast, in the facial region, although both genes are expressed in the frontonasal process at El0.5 (compare Fig.  4b and c) , it is clear that Msx2 expression is much more distally restricted than Msxl expression. This is not modified in the homozygous mutant. We therefore conclude that the mutant phenotype, seen in the snout may be due to a lack of compensation by Msx2. On the other hand, both Msxl (Fig. 4a,b) and Msx2 (Fig. 4c,d ) are expressed in the first branchial arch which will contribute to the upper and lower j aws.
Discussion

Homologous recombination
Given the absence of a striking mutant phenotype, the first question is whether the modification of the Msxl gene has created a true null mutation. The cumulative interactions of residues through the whole homeodomain contribute to the binding specificity of homeodomain proteins, including Msxl. Furthermore, residues located in both the N-terminal arm and helix III need to be compatible to give the right binding affinity and specificity; the homeodomain must be considered as a whole, in which multiple segments contribute to the overall DNA-peptide interaction (Isaac et al., 1995) . Point mutations in helix III of the Msxl homeodomain abolish the binding of the protein to its consensus binding site (Zhang et al., 1996) . This region is translated from the sequence where we introduced the nlacZ reporter gene to generate a null Msxl allele (Fig. 1) . While this work was in progress, it was shown that the Msxl protein can act as a repressor molecule independently of its binding to DNA (Catron et al., 1995) . Repression is mediated by the homeodomaln, via its N-terminal ann which directly binds to TBP (TATAbinding proteins) in the transcription core apparatus Zhang et al., 1996) . The Nterminal arm of the homeodomain is still present in the mutated allele, but we think that this is nevertheless a null allele because the insertion of nlacZ into helix III of the homeodomain will disturb the three dimensional structure of the chimeric protein, particularly in the close vicinity of the insertion, and will prevent interactions between the Nterminal arm and helix IlL Furthermore, the nlacZ was integrated at the same restriction site where Satokata and Maas (1994) introduced the PMClneo gene in their construct, but the resulting fusion proteins are completely different. Since these two alleles give rise to qualitatively and quantitatively similar phenotypes, we suggest that both of them are null rather than hypomorphic.
Functional redundancy with Msx2 may explain the Msx l -/-mutant phenotype
In our Msxl mutant, in agreement with that previously described by Satokata and Maas (1994) , defects are almost exclusively confined to the facial region (snout, palate, middle ear bones and teeth), whereas most other sites where Msxl is strongly expressed appear to be normal. There are a number of possible explanations for these observations.
The Msxl protein may have a less essential function than expected during embryonic life. The mutant may suffer from some minor developmental defects which would only become deleterious during postnatal development. A mutation in the homeodomain of Msxl is responsible for selective tooth agenesis in a human family (Vastardis et al., 1996) . The mutation replaces an arginine with a proline. The fact that the arginine residue is conserved in msxrelated homeodomains from hydra to human suggests that it plays an important role in msx gene activity. The human mutation strongly impairs tooth development, as in the mice null mutants, but without affecting any other structure, even throughout postnatal life. This mutation, however, is of a completely different nature from the one we have generated, and actually leads to a dominant phenotype.
Msxl may be expressed in some tissues in which its product has no function at all, as Erickson (1993) proposed for some genes. To regulate gene expression, evolution may have generated a limited set of switches shared by several genes, with the only absolute rule being the requirement to turn on the genes where they are needed and turn them off where they are toxic. Catron et al. (1995) have proposed that Msxl function may not be mediated by DNA-homeodomain interactions but rather that the homeodomain binds to TBP in the transcriptional core apparatus; Msxl then needs a cofactor to mediate specific interactions with promoters Zhang et al., 1996) (Guichet et al., 1997; Yu et al., 1997) . This kind of mechanism may be common in development. The Msxl protein may be present at many sites in the embryo, but be non-functional without a cofactor.
Msxl may be replaced by a protein with similar biochemical properties, which would be coexpressed with it in many tissues. In an evolutionary sense, true genetic redundancy seems to be very unlikely since one of the genes should have decayed into a pseudogene (Brookfield, 1992) . However, duplications leading to redundant genes which are then able to diverge until co-opted to new functions is a very potent mechanism of evolution (reviewed in Holland et al., 1994) . The msx gene was duplicated and the resulting genes subsequently diverged when vertebrates emerged, but these genes maintained close biochemical properties, so that they may replace each other where they are coexpressed . Although Msxl and Msx2 are expressed at many common sites in the embryo, their patterns of expression are slightly different. In the Msxl -lmice, it is striking that among the expected defects arising from perturbation of inductive interactions, the only one which is observed is confined to teeth, where there cannot be any functional redundancy; Msx2 is preferentially expressed in dental ectoderm while Msxl is restricted to dental mesenchyme (MacKenzie et al., 1992; Satokata and Maas, 1994; Chen et al., 1996) . At other sites of ectoderm/ mesoderm interactions Msx2 is also expressed in the tissues concerned. We illustrate this for limb development where Msx2 transcripts are present in the apical ectodermal ridge and in the underlying mesenchyme. Although expression of Msx2 is apparently weaker than Msxl, and there is no upregulation in the Msxl-/-mutant, we would suggest that it is sufficient to compensate for the lack of Msxl. If this is the case, the more limited area of Msx2 gene expression which is mainly limited to anterior and posterior regions of the progress zone would indicate that it is here that msx function is critical in El0.5 embryos. Subsequently, the areas of Msxl and Msx2 expression overlap in the handplate and later in the interdigital region. The facial defects in the mutant affect both the upper and the lower jaw. It is striking that Msx2 expression in the embryonic frontonasal process is much more restricted than that of Msxl. Although the palate, for example, which is defective in Msxl -/-mice is derived from cells of the maxillary region of the first branchial arch where Msx2 expression clearly overlaps with Msxl expression, it is formed in close contact with the frontonasal process. Lack of Msxl protein in the frontal region of the face may well have repercussions for the correct development of underlying mandibular structures as well as leading to a shortening of the snout in the mutant.
Analysis of the double mutant should confirm the hypothesis that there is an Msx function in the embryo which may be fulfilled either by Msxl or Msx2 during development. 
Experimental procedures
Homologous recombination
A lacZ plasmid which contains the nuclear localization signal (n) as previously described (Bonnerot et al., 1987; Tajbakhsh et al., 1996) was introduced into a BglII site of the second exon of the mouse Msxl gene (Robert et al., 1989) , such that it interrupts the third helix of the homeodomain. The neomycin gene under the control of the thymidine kinase promoter (tkNeo), obtained from pMC1Neo (Stratagene) was introduced into the construct immediately after nlacZ for positive selection in ES cells. Thus, 3 kb and 3.5 kb of the Msxl gene sequences flank the nlacZ and tkNeo genes at the 5' and 3' ends, respectively. The A subunit of the diphtheria toxin gene (DTA) (Yagi et al., 1990) under the control of the tk promoter was introduced at the 5' end of the construct for negative selection (Fig. la) .
HM1 ES cells (a gift from D. Melton) (Magin et al., 1992 ) were prepared as previously described (Tajbakhsh et al., 1996) except that the DMEM medium was complemented with 10% foetal calf serum and 10 3 units/ml of LIF (GIBCO Life Sciences). A total of 1.6 x 108 cells were electroporated in two different experiments and grown in the presence of G418 for selection (300 #g/ml initially and then 100/zg/ml after sub-culture). Resistant clones were tested for/3-galactosidase activity and by Southern blotting. Genomic DNA was restricted with EcoRI; hybridization was performed with a 3.5 kbp (kilobase pairs) BgllI probe which hybridizes with most of the second exon and 3' untranslated regions. This probe reveals a 5 kbp hybridizing fragment with the normal allele and a 6 kb fragment with the mutated one. We obtained a total of 14 recombinant clones. Five clones were injected into blastocysts and four of them gave germ line transmission. The heterozygous mutants were backcrossed for 10 generations onto a C57BL/6J background.
Embryos were rinsed in PBS and fixed in 4% formaldehyde in PBS for 5-30 min, depending on the size of the embryo. After washing twice in PBS (at least 5 min each), embryos were stained in a solution containing 4 mM potassium ferricyanide, 4 mM potassium ferrocyanide, 2 mM MgC12, 400/~g/ml X-gal and 0.02% Nonidet P-40 in PBS at 32°C overnight with gentle agitation (Sanes et al., 1986) . X-Gal stocks were prepared in dimethyl sulfoxide at 40 mg/ ml and stored at -20°C.
Skeleton preparations
Newborn mice were recovered and sacrificed in dry ice, viscera were removed and the body was rinsed in water. They were subsequently placed for 30 s in water (55-60°C), skinned and stained overnight at room temperature (70% ethanol, 50 vol.; acetic acid, 8 vol.; Alcian Blue, 0.009%; Alizarin Red, 0.0045%). They were then differentiated in 96% ethanol for 1 h, digested for 6-8 h in 1% KOH and clarified with increasing concentrations of glycerol (modified from Kimmel and Trammell, 1981; Kuczuk and Scott, 1984) .
Whole-mount in situ hybridization
The Msxl probe corresponds to the 3' untranslated region of the gene as previously described (Lyons et al., 1992) . The Msx2 probe is a mixture of two fragments encompassing the 3' (nucleotides 1220-1479 of the published sequence (Monaghan et al., 1991) ) and 5' untranslated regions of the gene (a BamHI fragment, subclone of the Msx2 gene in phage P1; P. Barton, unpublished data). Whole-mount in situ hybridization was performed according to Henrique et al. (1995) .
